1. Home
  2. VPG vs NKTR Comparison

VPG vs NKTR Comparison

Compare VPG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VPG
  • NKTR
  • Stock Information
  • Founded
  • VPG 2009
  • NKTR 1990
  • Country
  • VPG United States
  • NKTR United States
  • Employees
  • VPG 2300
  • NKTR N/A
  • Industry
  • VPG Electrical Products
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • VPG Technology
  • NKTR Health Care
  • Exchange
  • VPG Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • VPG 283.7M
  • NKTR 247.9M
  • IPO Year
  • VPG N/A
  • NKTR 1994
  • Fundamental
  • Price
  • VPG $21.42
  • NKTR $1.07
  • Analyst Decision
  • VPG Hold
  • NKTR Buy
  • Analyst Count
  • VPG 1
  • NKTR 5
  • Target Price
  • VPG $31.00
  • NKTR $4.00
  • AVG Volume (30 Days)
  • VPG 101.9K
  • NKTR 1.7M
  • Earning Date
  • VPG 11-05-2024
  • NKTR 11-07-2024
  • Dividend Yield
  • VPG N/A
  • NKTR N/A
  • EPS Growth
  • VPG N/A
  • NKTR N/A
  • EPS
  • VPG 0.99
  • NKTR N/A
  • Revenue
  • VPG $323,397,000.00
  • NKTR $93,137,000.00
  • Revenue This Year
  • VPG N/A
  • NKTR N/A
  • Revenue Next Year
  • VPG $1.31
  • NKTR N/A
  • P/E Ratio
  • VPG $21.64
  • NKTR N/A
  • Revenue Growth
  • VPG N/A
  • NKTR 5.53
  • 52 Week Low
  • VPG $21.12
  • NKTR $0.42
  • 52 Week High
  • VPG $35.98
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • VPG 34.11
  • NKTR 33.03
  • Support Level
  • VPG $21.12
  • NKTR $1.33
  • Resistance Level
  • VPG $24.29
  • NKTR $1.43
  • Average True Range (ATR)
  • VPG 0.81
  • NKTR 0.10
  • MACD
  • VPG -0.14
  • NKTR -0.03
  • Stochastic Oscillator
  • VPG 9.17
  • NKTR 6.98

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates majority of its revenue from United States.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: